Puma Biotechnology (PBYI) Leases (2019 - 2025)
Historic Leases for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $6.1 million.
- Puma Biotechnology's Leases rose 1347.61% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 1347.61%. This contributed to the annual value of $4.6 million for FY2024, which is 4123.46% down from last year.
- Per Puma Biotechnology's latest filing, its Leases stood at $6.1 million for Q3 2025, which was up 1347.61% from $2.8 million recorded in Q2 2025.
- Puma Biotechnology's 5-year Leases high stood at $15.8 million for Q1 2021, and its period low was $2.8 million during Q2 2025.
- Over the past 5 years, Puma Biotechnology's median Leases value was $9.9 million (recorded in 2023), while the average stood at $9.6 million.
- Within the past 5 years, the most significant YoY rise in Puma Biotechnology's Leases was 1347.61% (2025), while the steepest drop was 5461.4% (2025).
- Puma Biotechnology's Leases (Quarter) stood at $14.0 million in 2021, then decreased by 18.94% to $11.4 million in 2022, then crashed by 31.42% to $7.8 million in 2023, then tumbled by 41.23% to $4.6 million in 2024, then surged by 34.24% to $6.1 million in 2025.
- Its last three reported values are $6.1 million in Q3 2025, $2.8 million for Q2 2025, and $3.7 million during Q1 2025.